Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

China · Delayed Price · Currency is CNY

11.12

-0.27 (-2.37%)

Nov 13, 2026, 3:00 PM CST

Market Cap	4.76B -21.3%
Revenue (ttm)	1.20B +14.2%
Net Income	135.65M -46.0%
EPS	0.32 -45.5%
Shares Out	428.49M
PE Ratio	34.81
Forward PE	23.17
Dividend	0.28 (2.54%)
Ex-Dividend Date	May 28, 2026

Volume	2,635,420
Open	11.41
Previous Close	11.39
Day's Range	11.10 - 11.51
52-Week Range	9.36 - 14.56
Beta	0.37
Analysts	Strong Buy
Price Target	14.55 (+30.85%)
Earnings Date	Oct 30, 2026

About SHA:688389

Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blood analyzers, and related testing reagents, serving hospitals, health check-up centers, and third-party medical testing institutions. The company also ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2008

Employees 1,896

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688389

Full Company Profile

Financial Performance

In 2025, SHA:688389's revenue was 1.04 billion, a decrease of -9.60% compared to the previous year's 1.15 billion. Earnings were 184.22 million, a decrease of -46.66%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 688389 stock is "Strong Buy." The 12-month stock price target is ¥14.55, which is an increase of 30.85% from the latest price.

Price Target

¥14.55

(30.85% upside)

Analyst Consensus: Strong Buy

Stock Forecasts